Negative Adaptive CRT Trial Yields Useful Clinical Messages

Adaptive resynchronization therapy can benefit patients with heart failure, intact atrioventricular conduction, and left bundle branch block, even though the AdaptResponse trial technically failed.

Related Keywords

Ohio ,United States ,Cleveland ,Switzerland ,Zurich ,Züsz ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Jan Steffel ,Bruce Wilkoff ,York Heart Association ,Cleveland Clinic Foundation ,University Of Zurich ,European Heart Rhythm Association ,Late Breaking Science ,Heart Rhythm Association ,New York Heart Association ,Safety Monitoring Board ,Medscape Medical ,Heart Failure ,Biventricular Pacing ,Shiv ,Cardiac Resynchronization Therapy ,Art ,Heart ,Cardiac Rate ,Heart Rate ,Left Bundle Branch Block ,Transvenous Cardiac Pacing ,Transvenous Pacing ,Ndocardial Pacing ,Pacemaker ,Atrioventricular Block ,Kav Block ,Dual Chamber Pacemaker ,Odd ,Kddr ,Clinical Research ,Clinical Trials ,Linical Studies ,Medical Literature ,Books ,Textbooks ,Ournals ,